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A 4.5-month-old baby girl presented to hospital with a 2-day history of watery diarrhea and fever. Rehydration and electrolytic
balance were restored with intravenous ﬂuid therapy followed by oral rehydration solution but diarrhea did not improve by the
fourth day of hospitalization despite treatment with a probiotic. The patient was next treated with gelatin tannate, a medical
device recently marketed in Europe to control and reduce the symptoms of diarrhea in infants, children, and adults. The child’s
diarrhea improved considerably within the ﬁrst twelve hours and resolved completely within three days. Gelatin tannate might be
consideredasausefultreatmentcomplementarytooralrehydrationsolutionforthetreatmentofdiarrheaininfantswithrotavirus
gastroenteritis.
1.Introduction
Rotavirus is the leading cause of acute gastroenteritis in
infants and children in Europe [1]. Despite improvement
of public health across Europe and availability of a vaccine
against rotavirus licensed in several countries worldwide,
the incidence of intestinal infection remains high and thus
an important clinical problem with an equally substantial
socioeconomic burden,althoughmortality hasfallensharply
in recent decades. The burden of rotavirus in 2006 for
Belgium (prevaccination) was 2.5-fold higher than the
median rate estimated for other European countries (3 per
1000, range 0.3–11.9 per 1000) but showed a similar age
distribution to neighboring countries [2–4]. The incidence
of diarrhea ranges from 0.5 to 1.9 episodes per child
per year in children younger than 3 years old in Europe
[1]. Although a mild disease in most European countries,
acute gastroenteritis is associated with a high number of
hospitaladmissionsandhighsocioeconomiccosts.Rotavirus
is the most severe enteric pathogen of diarrhea in children.
Fever and frequency of vomiting more than twice per day
are common symptoms of rotavirus infection, which is
considered the main cause of severe dehydrating diarrhea.
Thesesignsarefrequentinchildrenhospitalizedfordiarrhea.
The author presents a case of gastroenteritis caused by
rotavirus in an otherwise healthy but slightly underweight
infant presenting with a 2-day history of severe diarrhea and
dehydration.
2. Case Presentation
A 4.5-month-old female presented to hospital with a 2-day
history of watery diarrhea and fever developed in the 12
hours before admission. The infant was reported to have had
10 watery stools over the previous 24 hours, during which
she became quite unsettled, crying a lot, whilst drinking
half her usual amount of liquids. There was no history of
vomiting.
Her medical history revealed delivery at term via emer-
gency cesarean section due to severe fetal distress, with a
birth weight of 2910g. Her Apgar score was 0-1 at one and
ﬁve minutes, respectively, after delivery requiring tracheal
intubation and transfer into neonatal intensive care unit. She
was put into induced coma and active hypothermia for 72
hours. The infant was extubated on the fourth day of life,
followed by reestablishment of enteral nutrition by day 5.
She was fed exclusively on formula milk from birth. An2 Case Reports in Gastrointestinal Medicine
MRI performed on day 5 showed signs of severe hypoxic-
ischemic encephalopathy. Followup after discharge was very
irregular and the infant did not receive any vaccines up until
the current hospitalization episode. Her weight curve was a
reason for concern; indeed, her weight two weeks before the
current admission to hospital was 4390g.
On the day of presentation, physical examination re-
vealed an alert but irritable and ill-appearing infant with
a temperature of 39.9◦C, heart rate between 170 and 190
beats/min, respiratory rate between 40 and 80 breaths/min,
blood pressure of 102/55mmHg, and oxygen saturation by
pulse oximetry of 100%. The child’s weight at admission into
hospital was 3990g, meaning she lost 10% of the previous
reported weight. The skin was pale grey, tenting skin turgor,
dry lips and dry buccal mucosa, normal looking eyes but
reduced tears, soft fontanele, and capillary reﬁll time of 3
seconds. The urine output was also decreased. Heart and
lung examination were normal except for tachycardia; the
abdomen was swollen and slightly painful on palpation,
no hepatosplenomegaly. Abdominal and thorax radiographs
were normal. There were no signs of meningeal irritation.
Laboratory tests showed hemoglobin 12.6g/dL, white blood
cells 11970/mm3 (PMN = 7590), platelets 1085000/mm3,
and C-reactive protein was less than 0.05mg/dL (Table 1).
Routine stool specimen tested positive for rotavirus antigen
(Vikia Rota-Adeno, Biomerieux), whilst results for blood
and urine culture were negative. Serum electrolytes were
signiﬁcant for a sodium concentration of 146mEq/L and
a bicarbonate level of 8mEq/L. Blood urea nitrogen was
61mg/dL.
The patient was admitted to the hospital and intravenous
ﬂuid therapy was promptly initiated to correct the infant’s
tachycardia, polypnea, and low blood pH, by attempting
volume repletion with 2 subsequent doses of 0.9% sodium
chloride at 20mL/kg over 60 minutes. A solution containing
dextrose5%pluselectrolyteswasadministeredsoonafterthe
second dose of normal saline to attain the slow correction
of hypernatremia. Diuresis was reestablished within four
hours of rehydration therapy. Digestive losses of water and
electrolytes were oﬀset by oral rehydration solution (ORS),
at an initial dose of 10mL/kg and thereafter replaced volume
per volume depending on the amount of stool losses. Enterol
(yeast of Saccharomyces boulardii) was initiated as an adju-
vant treatment to ORS. Metabolic acidosis was diﬃcult to
correct during the ﬁrst 48 hours because of large liquid losses
duetodiarrhea.Despitethediﬃcultiesexperiencedtorestore
the electrolytic balance, the baby showed an outstanding
digestive tolerance throughout the entire hospital stay, which
allowed continuation of enteral nutrition with lactose-free
formula milk (Novalac Diarinova).
At 24 hours after admission, hyperleukocytosis with
neutrophilia and increased C-reactive protein in blood
(Table 1) prompted antibiotic treatment with ceftriaxone
100mg/kg/day, which was suspended three days later due
to negative bacterial culture results; stools were not tested
for the presence of Clostridium diﬃcile. Adjuvant treatment
with gelatin tannate was initiated on the third day of
hospitalization.Metabolicacidosisimprovedinthefollowing
48 hours along with a substantial reduction in stool output.
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Figure 1: Evolution of both number of daily stools and baby’s
body weight during hospitalization. Stool count on day one (∗)
corresponds to the number of stools since the baby was admitted
to hospital from midday on that day.
The baby was exclusively fed by oral route from the ﬁfth
day.Thepatient’shistoryincludedalsoantiplatelettreatment
(aspirin 5mg/kg/day for one month) due to thrombocytosis.
Gelatin tannate was ﬁrst administered in the afternoon
of the third day of hospitalization, one sachet every 6
hours, ﬁve days after the start of diarrhea. The patient
presented to hospital with a 2-day history of 10 watery
stools a day, followed by a slight increase in the number
of liquid stools during the ﬁrst 4 days of hospitalization
(Figure 1). A considerable reduction of the total number of
daily stools was registered in the ﬁrst 24 hours after initiating
antidiarrheal treatment with gelatin tannate, with four and
three watery stools registered in the ﬁrst 12 and 24 hours,
respectively. The number and volume of stools continued to
diminish substantially during the second day of treatment,
with the diarrhea practically resolving by the third day of
treatment with gelatin tannate (only three stools of almost
normal consistency). Gelatin tannate was administered-
dissolved in ORS, except for the ﬁrst dose (dissolved in
milk). The progress was favorable, however, the patient was
discharged from hospital three days later in order to achieve
optimum nutrition and to ensure vaccinations were up to
date. Upon discharge from hospital the baby’s weight was
4.640kg.
3. Discussion
Reduced osmolality oral rehydration solution and early
refeeding remain central to optimal management of mildly
to moderately dehydrated children [1]. Acute gastroenteritis
is usually self-limited but a very few antidiarrheal drugs can
be considered for more severe cases in infants and children,
when symptoms of fever, vomiting and severe diarrhea
can seriously aggravate dehydration. Selected probioticsCase Reports in Gastrointestinal Medicine 3
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(Lactobacillus GG and Saccharomyces boulardii)a r eu s e dt o
improve intestinal microbial balance and may prove beneﬁ-
cial, although sometimes mild, in reducing the duration of
infectious diarrhea mainly of viral etiology [5]. Antibiotics
are usually not recommended [1].
Fluid and electrolyte replacement are the mainstay of
treatment to prevent and correct severe dehydration and
acidosis. Oral rehydration therapy is usually suﬃcient unless
the subject is vomiting, and/or losses are very severe. In the
present case, IV management with isotonic NaCl followed
by the administration of a solution containing dextrose 5%
plus electrolytes to restore volume depletion and correct
hypernatremia, respectively, were also necessary.
Strong suspicion of underlying bacterial infection after
increase of infection parameters in the 24-hour post-
admission laboratory results led to the administration of
ceftriaxone discontinued 3 days afterwards due to negative
bacterial culture results.
Given the diarrhea did not improve within the four ﬁrst
days of hospitalization, gelatin tannate was since prescribed.
Gelatin tannate has been recently approved in Europe as
a medical device to control and reduce the symptoms
associated with diarrhea. The use of tannates for the
treatment of diarrhea in infants and children has been
proven to be eﬀective and safe in previous studies, leading
to signiﬁcant decrease of both the duration of diarrhea and
number of watery stools within the ﬁrst 24 to 48 hours
either against placebo [6]o rc o m p a r e dt oO R Sa l o n e[ 7].
The mechanism of action for gelatin tannate is not entirely
clear but it is thought to act locally on the intestinal wall
via the formation of a protein-based ﬁlm thereby protecting
the gut from the irritable eﬀect of intestinal secretions
responsible for intestinal toxemia. Tannins are well known
for their astringent properties, permitting the precipitation
of proinﬂammatory mucoproteins from the intestinal mucus
responsible for local inﬂammation and elimination through
the feces [8, 9].
The case reported here contributes to the relatively
scarce evidence on the eﬃcacy of gelatin tannate in treating
diarrhea in infants and children with acute gastroenteritis.
More research is needed to elaborate on these ﬁndings.
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